Cancer AI and Informatics
Specialized Pathology and Oncology Solutions for the Entire Cancer Patient Journey
In the fight against cancer, moments matter.
Reducing the time to first diagnosis. Access to treatment. Research breakthroughs. These critical goals share a commonality. They can benefit from innovative pathology and oncology AI and workflow solutions.
Inspirata removes case throughput inefficiencies and provides the essential toolsets required for care teams to optimize clinical decision making.
Why Inspirata?
Cancer Focus – Inspirata solutions reflect a domain expertise in oncology AI and informatics, and a commitment to delivering innovation at all points in the cancer patient journey.
Interoperability – as proponents of open architecture, all Inspirata solutions have been developed to ensure compatibility with relevant pathology and oncology ecosystem providers.
Higher Standard of Care – by reducing inefficiencies and affording access to new revenue streams, Inspirata helps customers maximize the opportunity for improved patient outcomes.
Inspirata in Action
Health Ontario
Covering nearly 40% of Canada's population and representing a database comprised of 30.8+ million cytology reports across 7.4 million patients, Inspirata's technology powers the Government of Ontario's province-wide cervical screening electronic health record.
Cytobase
Explore how Inspirata’s collaboration with Ontario Health and a consortium of local private laboratories has improved the collection and application of cervical cancer data for Canada’s most populous province.
National Cancer Institute
Utilized across its network of over 300+ major hospitals and 14 central state registries, Inspirata’s AI helps automate and accurately identify and report cancer data for the National Cancer Institute of the United States (NCI).
SEER Program
Understand how the NCI Surveillance, Epidemiology, and End Results (SEER) program, and the thousands of researchers, clinicians, public health officials, and policymakers that use SEER data, are supported by Inspirata’s oncology AI.
Cancer Research UK
Guy’s and St Thomas’ NHSFT, King’s Health Partners ECMC, Cancer Research UK and Inspirata are collaborating to validate how AI can help automate the process by which patients with cancer are matched to early phase clinical trials.
Michelle Mitchell, CEO
"We are excited to support a project that seeks to aid clinicians in the complex and time-consuming task of matching patients to suitable trials.”
Cancer Council Victoria
Significantly outperforming manual benchmarks, Inspirata’s oncology-specific AI has been validated by Cancer Council Victoria as possessing 100% sensitivity and 98% specificity for cancer reporting completeness and accuracy.
Dr. Catherine Shang
"Inspirata has greatly improved our case-finding completeness and contributed to a more accurate and precise diagnosis and cancer classification.”
Health Data Research UK
Responding to an urgent requirement for new insights on COVID-19, an Inspirata and HDR UK collaboration successfully deployed its AI to surface key entity relationships contained within the 200K+ scientific materials published during the pandemic.
COVID-19 Research
Learn how Inspirata, working with HDR UK, applied its AI to find connections between disease, medication and procedures identified from title and abstracts of 195,958 COVID-19 related publications (CORD-19 Dataset).
Ohio State University
Inspirata is proud to support OSU in its efforts to advance cancer research, having helped the institution to arrive at the world’s single largest repository of whole slide images. Currently, 1.8 million slides scanned and counting!
Dr. Anil Parwani
“Embracing digitization while drawing on new tool-sets predicated on AI to really interrogate the data is the only scalable way for us to realize the kind of downstream advances in patient care we crave."
Cancer Council Victoria
Significantly outperforming manual benchmarks, Inspirata’s oncology-specific AI has been validated by Cancer Council Victoria as possessing 100% sensitivity and 98% specificity for cancer reporting completeness and accuracy.
Dr. Catherine Shang
"Inspirata has greatly improved our case-finding completeness and contributed to a more accurate and precise diagnosis and cancer classification.”
Health Data Research UK
Responding to an urgent requirement for new insights on COVID-19, an Inspirata and HDR UK collaboration successfully deployed its AI to surface key entity relationships contained within the 200K+ scientific materials published during the pandemic.
COVID-19 Research
Learn how Inspirata, working with HDR UK, applied its AI to find connections between disease, medication and procedures identified from title and abstracts of 195,958 COVID-19 related publications (CORD-19 Dataset).
Health Ontario
Covering nearly 40% of Canada's population and representing a database comprised of 30.8+ million cytology reports across 7.4 million patients, Inspirata's technology powers the Government of Ontario's province-wide cervical screening electronic health record.
Cytobase
Explore how Inspirata’s collaboration with Ontario Health and a consortium of local private laboratories has improved the collection and application of cervical cancer data for Canada’s most populous province.
National Cancer Institute
Utilized across its network of over 300+ major hospitals and 14 central state registries, Inspirata’s AI helps automate and accurately identify and report cancer data for the National Cancer Institute of the United States (NCI).
SEER Program
Understand how the NCI Surveillance, Epidemiology, and End Results (SEER) program, and the thousands of researchers, clinicians, public health officials, and policymakers that use SEER data, are supported by Inspirata’s oncology AI.
Inspirata in the News
Healthcare Technology Leader Laure Tessier-Delivuk Joins...
Experienced Healthcare Leader Laurie Smith Joins...
